Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Mar 10;36(5):928–941. doi: 10.1161/ATVBAHA.115.306725

Table 1.

Top Multitissue KD Genes in Gene Regulatory and Protein–Protein Interaction Networks Ranked by KD Analysis Meta P Value Across CAD Gene Lists and Networks

KD Ad Ao Ar Bl Br CM Ht Is Kd Li Mu PP SM VE Tissue Consist List Consist Meta P Values KD P Values in 1000G CAD GWAS
DUSP6 0 2 2 0 0 3 0 0 0 0 0 0 6 2 5 15 1.35e−34 1.47e−03
DUSP1 0 1 6 0 0 0 0 0 0 0 0 0 4 0 3 11 2.77e−26 2.07e−03
KNG1 0 0 0 0 5 0 0 0 0 0 4 0 0 0 2 9 8.60e−15 2.65e−03
F2 5 0 0 0 0 0 0 0 0 0 4 0 0 0 2 9 4.22e−13 2.62e−04
APOA1 4 0 0 0 5 0 0 0 0 0 2 0 0 0 3 11 1.93e−09 5.60e−05
HGD 0 0 0 0 4 0 0 0 0 0 5 0 0 0 2 9 1.05e−08 4.15e−03
GBP1 2 0 0 2 0 0 0 0 0 0 0 0 0 2 3 6 3.41e−08 6.76e−04
GBP2 0 0 0 2 0 0 0 0 2 0 0 0 2 0 3 6 1.60e−07 6.76e−04
ANXA1 0 0 3 0 0 0 0 0 0 0 0 0 1 0 2 4 9.70e−07 9.12e−03
PLG 4 0 0 0 0 0 0 0 0 1 0 0 0 0 2 5 3.13e−06 2.88e−34
COL4A2 0 0 0 0 0 0 0 0 0 0 4 3 0 0 2 7 4.04e−06 1.83e−10
MSN 0 0 0 0 0 0 0 0 0 2 0 0 0 1 2 3 7.30e−06 1.00e+00
ANXA2 0 0 0 0 0 2 0 0 0 0 0 2 0 0 2 4 1.47e−05 3.43e−03
CXCL12 1 0 0 0 0 1 0 0 0 3 1 0 0 0 4 6 2.28e−05 2.95e−10
ABCG5 1 0 0 0 0 0 0 0 0 2 0 0 0 0 2 3 3.70e−05 1.35e−07
APOB 2 0 0 0 0 0 0 0 0 0 0 3 0 0 2 5 6.48e−05 3.09e−08
ADM 0 0 1 0 0 0 0 0 0 0 0 0 1 0 2 2 7.95e−05 2.77e−04
RDH16 0 0 0 0 2 0 0 0 0 0 2 0 0 0 2 4 0.000115 3.17e−03
PAPSS2 0 0 0 0 0 1 0 0 0 0 0 0 2 0 2 3 0.000136 4.68e−03
APOA5 0 0 0 0 1 0 0 0 0 2 0 0 0 0 2 3 0.0005 5.60e−05
FN1 0 0 0 0 0 0 0 0 1 0 0 3 0 0 2 4 0.000759 5.14e−07
IRF7 1 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0.000912 8.68e−03

The numbers in each cell represent how many of the 7 CAD gene lists yielded the KD using the specific tissue network. Ad indicates adipose; Ao, aorta; Ar, artery; Bl, blood; Br, brain; CAD, coronary artery disease; CM, cardiac muscle; GWAS, genome-wide association studies; Ht, heart; Is, islet; Kd, kidney; KD, key driver; Li, liver; Mu, muscle; PP, protein–protein interaction; SM, smooth muscle; and VE, vascular endothelium networks.